Formula UHF
Natural health product licensed in Canada
- Licence holder
- 2131521 Ontario Ltd.
- NPN or DIN-HM
- 80071968
- Status
- Inactive licence
- Licence date
- 12 August 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Frangula purshiana Source : Écorce âgée | 175 milligramme | Not calculated |
| Linum usitatissimum Source : Graine(s) | 150 milligramme | Not calculated |
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 50 milligramme | 12.5 milligramme | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 25 milligramme | Not calculated |
| Plantago ovata Source : Enveloppe | 100 milligramme | Not calculated |
| Senna alexandrina Source : Feuille | 75 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 milligramme | 25 milligramme | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Graine(s) | 20 milligramme | Not calculated |
| Silybum marianum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2.5 g Potency : 100 milligramme Silymarin | 125 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Stimulant laxative. For the short-term relief of occasional constipation. Promotes bowel movement (by direct action on the large intestine). Used in Herbal Medicine to help relieve digestive disturbances/dyspepsia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80071968
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.